使用TEG凝血测试预测PAD患者抗血小板药物的出血风险

Adriana A Rodriguez Alvarez1, Isabella Ferlini Cieri1, Mounika Boya1

  • 1Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA 02114 USA.

Journal of surgery and research
|August 20, 2025
PubMed
概括

通过血小板测绘 (TEG- PM) 测量的高血小板抑制和低最大幅度的腺二酸盐可以预测在接受抗血小板治疗的外周动脉疾病 (PAD) 患者的出血风险.